Ibritumomab Intravenous and Olmesartan Medoxomil and Hydrochlorothiazide
Determining the interaction of Ibritumomab Intravenous and Olmesartan Medoxomil and Hydrochlorothiazide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: hydrochlorothiazide / olmesartan
Brand name: Benicar HCT
Synonyms: Hydrochlorothiazide and olmesartan, Olmesartan and Hydrochlorothiazide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide
- Ibritumomab Intravenous-Olmesartan, Amlodipine, and Hydrochlorothiazide
- Ibritumomab Intravenous-Olodaterol
- Ibritumomab Intravenous-Olodaterol and tiotropium
- Ibritumomab Intravenous-Olodaterol Hydrochloride
- Ibritumomab Intravenous-Olodaterol inhalation
- Olmesartan Medoxomil and Hydrochlorothiazide-Ibritumomab Tiuxetan
- Olmesartan Medoxomil and Hydrochlorothiazide-Ibrutinib
- Olmesartan Medoxomil and Hydrochlorothiazide-Ibrutinib Capsules
- Olmesartan Medoxomil and Hydrochlorothiazide-Ibrutinib Tablets
- Olmesartan Medoxomil and Hydrochlorothiazide-Ibu
- Olmesartan Medoxomil and Hydrochlorothiazide-IBU Tablets